Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment
ACS Nano · 2025
DOI: 10.1021/acsnano.5c08006 ↗At a glance
Journal article in ACS Nano, 2025. Written by Jingwen Xie and 7 co-authors. Institution: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Major MEDLINE topics: Antioxidants, Gastrointestinal Microbiome, Colitis, Ulcerative, Colitis. Cited 20 times so far (Crossref); 56 references. Funded by: Zhejiang University, National Key Research and Development Program of China, Medical Science and Technology Project of Zhejiang Province.
Abstract (original language)
Ulcerative colitis (UC) involves a complex interplay of mucosal inflammation, intestinal barrier dysfunction, and gut dysbiosis, all exacerbated by elevated reactive oxygen species (ROS). Existing therapies often fail to concurrently address these interrelated pathologies. Here we present an orally administrable nanocage system that targets both host cells and gut microbiota and can simultaneously address immune dysregulation, epithelial damage, and microbial imbalances for UC treatment when loaded with antioxidant enzymes. This system features a poly(tertiary amine oxide) (PTAO)-based zwitterionic shell and ROS-labile cross-linkers around individual protein molecules. This structure provides robust cargo protection and retention during gastrointestinal transit and enables ROS-triggered release at inflamed sites. Upon internalization by intestinal epithelial cells and macrophages, the nanocages can be directed to mitochondria for efficient ROS scavenging, which promotes epithelial repair and macrophage repolarization. Moreover, the PTAO shell provides bacterial permeability that allows direct enzyme delivery into gut microbes, thus protecting them from oxidative damage and restoring microbial balance. In mouse models of UC and acute radiation colitis, this multifunctional system effectively alleviated inflammation, restored gut homeostasis, and reduced colonic damage, demonstrating its promising therapeutic potential for colitis treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
ORCID profiles: Jiajia Xiang, Shiqun Shao, Youqing Shen
Funding
- Zhejiang University
- National Key Research and Development Program of China
- Medical Science and Technology Project of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Natural Science Foundation of Zhejiang Province
Cite
APA
Xie, J., Si, J., Chen, Y., Ding, H., Cao, Y., Xiang, J., Shao, S., & Shen, Y. (2025). Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment. ACS Nano. https://doi.org/10.1021/acsnano.5c08006
Vancouver
Xie J, Si J, Chen Y, Ding H, Cao Y, Xiang J, et al. Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment. ACS Nano. 2025. doi:10.1021/acsnano.5c08006
BibTeX
@article{Xie2025,
author = {Xie, Jingwen and Si, Jingxing and Chen, Yuping and Ding, Hanchen and Cao, Yangyang and Xiang, Jiajia and Shao, Shiqun and Shen, Youqing},
title = {Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c08006}
}
EUVIMED